Clotting Factors

Product #

Description

Add to Cart

A0472 Acetyl-Ala-Leu-Cys-Asp-Asp-Pro-Arg-Val-Asp-Arg-Trp-Tyr-Cys-Gln-Phe-Val-Glu-Gly-NH2 [Disulfide bridge: 3-13] ≥95% (HPLC)
A8849 α2-Antiplasmin from human plasma lyophilized powder, ≥5 units/mg protein
A9141 Antithrombin III from bovine plasma lyophilized powder, 200-400 units/mg protein (E1%/280 = 6.5)
A2221 Antithrombin III from human plasma lyophilized powder, ≥95% (SDS-PAGE)
C4615 Cloricromene ≥98% (HPLC), solid
F9302 Factor X Activated (Xa) from bovine plasma aqueous glycerol solution
F3301 Factor Xa chromogenic substrate solid
F8630 Fibrinogen from bovine plasma Type I-S, 65-85% protein (≥75% of protein is clottable)
F4883 Fibrinogen from human plasma 35-65% protein (≥90% of protein is clottable).
F3379 Fibrinopeptide B human ≥97% (HPLC)
F3254 Fibrinopeptide A human ≥96% (HPLC)
F3261 [Glu1]-Fibrinopeptide B human ≥90% (HPLC)
SML0028 FR-171113 ≥98% (HPLC)
SML0714 FSLLRY-NH2 trifluoroacetate salt ≥98% (HPLC)
G1895 Gly-Pro-Arg-Pro ≥97% (HPLC)
G5779 Gly-Pro-Arg-Pro amide ≥97% (HPLC)
SML0418 ML-161 ≥98% (HPLC)
P1867 Plasmin from human plasma lyophilized powder, ≥2.0 units/mg protein
P9156 Plasminogen from bovine plasma lyophilized powder, ≥2.0 units/mg protein
R7752 Ristomycin monosulfate ≥90% ristocetin A basis (balance primarily Ristocetin B)
T7513 Thrombin from bovine plasma lyophilized powder, ≥2,000 NIH units/mg protein (E1%/280 = 19.5)
T1063 Thrombin from human plasma lyophilized powder, ≥2800 NIH units/mg protein (E1%/280, 18.3)
T4393 Thrombin from human plasma lyophilized powder, 1500-3500 NIH units/mg protein (E1%/280, 18.3), cell culture tested
T3068 Thrombin generation chromogenic substrate ≥90% (TLC), solid
T2943 Tissue plasminogen activator chromogenic substrate ≥95% (HPLC), solid
T6140 N-(p-Tosyl)-Gly-Pro-Lys 4-nitroanilide acetate salt plasmin substrate